Health, MedTech and BioTech

Buckworths advises health, medical technology, and biotech start-ups and scale-ups across the UK. These are highly regulated sectors, and having specialist legal advice at every stage of growth is essential.

We advise on R&D agreements, licensing arrangements, supply agreements, and service contracts. We advise on IP protection for medical innovations, including trademark registration, copyright in software and publications, and technology transfer agreements. We put NDA and confidentiality frameworks in place around sensitive research and development activity.

Data protection is particularly complex in health and MedTech, especially where businesses handle patient data or health-related personal information. We advise on GDPR compliance, DPAs, privacy policies, and data security governance.

For businesses seeking investment, we advise on SEIS and EIS, advance assurance, VC and angel funding, term sheets, and investment round documentation. We assist with shareholder agreements, cap table management, and governance. For M&A activity, licensing deals, or exit, our corporate and M&A teams provide full support.

Book a free consultation to discuss your health, MedTech, or BioTech business.


Our Services


FAQs

MedTech products can be protected through a combination of patents, registered designs, trademarks, and copyright in technical documentation and software. The right combination depends on the nature of the product. We advise on IP strategy for MedTech businesses and work alongside patent attorneys where patent protection is being sought.

Health data is special category data under GDPR and attracts the highest level of regulatory protection. Processing it requires a specific legal basis and a substantial public interest condition. FinTech and MedTech businesses handling health data also need to comply with the Digital Technology Assessment Criteria if their products are used in NHS settings. We advise health technology businesses on the full scope of their data protection obligations.

Yes, provided the company meets the eligibility conditions. Most MedTech and BioTech businesses qualify as they carry on a qualifying trade and are typically research and development focused, which the schemes are designed to support. We assess eligibility, manage the advance assurance process with HMRC, and achieve a 99% success rate on first submission.